Sarah J. Menashe
YOU?
Author Swipe
View article: Supplementary Figure S3 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Supplementary Figure S3 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
Supplementary Figure S3. Expression of FOLR1 in normal tissues.
View article: Supplementary Figure S4 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Supplementary Figure S4 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
Supplementary Figure S4. FOLR1-negative control, Kasumi-1.
View article: Figure 3 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Figure 3 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
In vivo functional evaluation of FH FOLR1-CART in a localized U-2 OS xenograft model. A, Average radiance emitted by tumor measured over 180 days from intrafemoral tumor inoculation in mice treated with FH FOLR1-CART vs. NT T…
View article: Figure 5 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Figure 5 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
FH FOLR1-CART antitumor activity against patient-derived osteosarcoma cell lines in vitro. A, FOLR1 expression detected by flow cytometry by a panel of patient-derived osteosarcoma cell lines OS186, OS9, OS525, OS766, OS742, …
View article: Figure 2 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Figure 2 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
FH FOLR1-CART antitumor activity against U-2 OS osteosarcoma cell line in vitro. A, FOLR1 expression detected by flow cytometry by U-2 OS, WSU-AML (standard M7, FOLR1-positive AML), and Kasumi (standard FOLR-negative AML). Re…
View article: Figure 4 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Figure 4 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
In vivo functional evaluation of FH FOLR1-CAR T cells in a metastatic U-2 OS xenograft model. A, Average radiance of pulmonary osteosarcoma disease measured over 180 days from tumor inoculation by tail vein in mice treated wi…
View article: Supplementary Figure S1 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Supplementary Figure S1 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
Supplementary Figure S1. Clinical characteristics of PDX specimens generously provided by the lab of Dr. E. Alejandro Sweet-Cordero at the University of California, San Francisco.
View article: Figure 6 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Figure 6 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
In vivo functional evaluation of FH FOLR1-CAR T cells in metastatic PDX model. A, Average radiance of pulmonary PDX OS9 disease measured over 180 days from tumor inoculation by tail vein in mice treated with FOLR1-CART vs. NT…
View article: Supplementary Figure S5 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Supplementary Figure S5 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
Supplementary Figure S5. In vivo human T cell detection by flow cytometry.
View article: Figure 1 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Figure 1 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
FOLR1 expression by osteosarcoma from various genomic databases. A, mRNA expression of FOLR1 in various pediatric malignancies from the St. Jude PCGP database. Increased FOLR1 mRNA expression demonstrated in osteosarcoma, as well as…
View article: Data from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Data from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
Metastatic and relapsed osteosarcoma remains difficult to treat despite advanced surgical techniques, intensified chemotherapy, and targeted therapies. Adoptive immunotherapies such as chimeric antigen receptor (CAR) T cells are in their n…
View article: Supplementary Figure S2 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Supplementary Figure S2 from Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
Supplementary Figure S2. FOLR1 CAR construct and lentiviral transduction efficiency.
View article: Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma
Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma Open
Metastatic and relapsed osteosarcoma remains difficult to treat despite advanced surgical techniques, intensified chemotherapy, and targeted therapies. Adoptive immunotherapies such as chimeric antigen receptor (CAR) T cells are in their n…
View article: Introduction to the mini symposium on imaging of intersex and gender diverse youth
Introduction to the mini symposium on imaging of intersex and gender diverse youth Open
View article: High sensitivity methods for automated rib fracture detection in pediatric radiographs
High sensitivity methods for automated rib fracture detection in pediatric radiographs Open
View article: 45° FLEXION ANTEROPOSTERIOR ELBOW RADIOGRAPHS IMPROVE DIAGNOSTIC ACCURACY OF CAPITELLUM OSTEOCHONDRITIS DISSECANS
45° FLEXION ANTEROPOSTERIOR ELBOW RADIOGRAPHS IMPROVE DIAGNOSTIC ACCURACY OF CAPITELLUM OSTEOCHONDRITIS DISSECANS Open
Background: The initial diagnosis of capitellum osteochondritis dissecans (OCD) is typically confirmed using standard anteroposterior (AP) and lateral elbow radiographs, despite low sensitivity, which is approximately 44-47%. An AP image o…
View article: Pediatric radiologic manifestations of COVID-19
Pediatric radiologic manifestations of COVID-19 Open
View article: Issue Information
Issue Information Open
No abstract is available for this article.
View article: Erratum to: Ultrasound-guided joint injections for MR arthrography in pediatric patients: how we do it
Erratum to: Ultrasound-guided joint injections for MR arthrography in pediatric patients: how we do it Open